UTI Stock Analysis: Universal Technical | NYSE
Education & Training Services | NYSE, USA | Market Cap: 2.080m USD | 12M Return: 30% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 38.9M
EPS Trend: 84.8%
Qual. Beats: -1
Rev. Trend: 97.4%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Universal Technical Institute, Inc. (NYSE: UTI) is a U.S.-based provider of postsecondary education focused on transportation, skilled trades, and healthcare career training. Founded in 1965 and headquartered in Phoenix, Arizona, the company operates through two segments-UTI and Concorde-offering certificate, diploma, and degree programs across its campuses. In addition to core instructional programs, UTI delivers manufacturer-specific advanced training, including student-paid electives at its campuses and manufacturer- or dealer-sponsored training at dedicated training centers, serving students, industry partners, and local communities.
As a for-profit education services company within the Consumer Discretionary sector, UTIs business model combines traditional tuition-funded programs with revenue from manufacturer and dealer partnerships, which help align curriculum with industry workforce needs. The U.S. skilled trades and healthcare workforce shortage has supported demand for vocational training providers, and UTIs focus on hands-on, career-oriented programs distinguishes it from traditional four-year institutions.
- New student enrollment growth accelerates across transportation programs
- Concorde healthcare segment revenue outpaces UTI transportation segment
- Title IV funding rules and borrower defense regulations pressure for-profit education margins
| Net Income: 42.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -9.67 > 1.0 |
| NWC/Revenue: 4.13% < 20% (prev 1.71%; Δ 2.42% < -1%) |
| CFO/TA 0.10 > 3% & CFO 82.2m > Net Income 42.7m |
| Net Debt (339.7m) to EBITDA (112.0m): 3.03 < 3 |
| Current Ratio: 1.17 > 1.5 & < 3 |
| Outstanding Shares: last quarter (55.7m) vs 12m ago 0.53% < -2% |
| Gross Margin: 48.64% > 18% (prev 49.24%; Δ -0.61% > 0.5%) |
| Asset Turnover: 110.5% > 50% (prev 108.6%; Δ 1.87% > 0%) |
| Interest Coverage Ratio: 13.25 > 6 (EBIT TTM 58.1m / Interest Expense TTM 4.39m) |
| A: 0.04 (Total Current Assets 243.8m - Total Current Liabilities 207.9m) / Total Assets 852.2m |
| B: 0.13 (Retained Earnings 114.8m / Total Assets 852.2m) |
| C: 0.07 (EBIT TTM 58.1m / Avg Total Assets 786.3m) |
| D: 0.66 (Book Value of Equity 339.9m / Total Liabilities 512.3m) |
| Altman-Z'' = 1.91 = BBB |
| DSRI: 1.23 (Receivables 51.4m/37.6m, Revenue 869.0m/782.7m) |
| GMI: 1.01 (GM 49.24% / 48.64%) |
| AQI: 0.91 (AQ_t 0.13 / AQ_t-1 0.15) |
| SGI: 1.11 (Revenue 869.0m / 782.7m) |
| TATA: -0.05 (NI 42.7m - CFO 82.2m) / TA 852.2m) |
| Beneish M = -2.80 (Cap -4..+1) = A |
As of July 30, 2026, the stock is trading at USD 41.04 with a total of 678,495 shares traded. Over the past week, the price has changed by +14.03%, over one month by -0.75%, over three months by +13.75% and over the past year by +30.00%.
Current recommended Stop Loss: 35.90 (which is 12.5% or 2 ATR below the current price).
Universal Technical has received a consensus analysts rating of 4.83. Therefore, it is recommended to buy UTI.
- StrongBuy: 5
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 43.7 | 6.4% |
P/E Trailing = 49.7105
P/E Forward = 43.4783
P/S = 2.3938
P/B = 6.12
P/EG = 2.895
Revenue TTM = 869.0m USD
EBIT TTM = 58.1m USD
EBITDA TTM = 112.0m USD
Long Term Debt = 127.8m USD (from longTermDebt, last quarter)
Short Term Debt = 23.7m USD (from shortTermDebt, last quarter)
Debt = 501.7m USD (from shortLongTermDebtTotal, last quarter) + Leases 185.5m
Net Debt = 339.7m USD (calculated: Debt 501.7m - CCE 162.0m)
Enterprise Value = 2.42b USD (2.08b + Debt 501.7m - CCE 162.0m)
Interest Coverage Ratio = 13.25 (Ebit TTM 58.1m / Interest Expense TTM 4.39m)
EV/FCF = 1000.0x (Enterprise Value 2.42b / FCF TTM 1.44m)
FCF Yield = 0.06% (FCF TTM 1.44m / Enterprise Value 2.42b)
FCF Margin = 0.17% (FCF TTM 1.44m / Revenue TTM 869.0m)
Net Margin = 4.91% (Net Income TTM 42.7m / Revenue TTM 869.0m)
Gross Margin = 48.64% ((Revenue TTM 869.0m - Cost of Revenue TTM 446.3m) / Revenue TTM)
Gross Margin QoQ = 46.70% (prev 49.99%)
Tobins Q-Ratio = 2.84 (Enterprise Value 2.42b / Total Assets 852.2m)
Interest Expense / Debt = 0.87% (Interest Expense 4.39m / Debt 501.7m)
Taxrate = 24.47% (13.8m / 56.5m)
NOPAT = 43.9m (EBIT 58.1m * (1 - 24.47%))
Current Ratio = 1.17 (Total Current Assets 243.8m / Total Current Liabilities 207.9m)
Debt / Equity = 1.48 (Debt 501.7m / totalStockholderEquity, last quarter 339.9m)
Debt / EBITDA = 3.03 (Net Debt 339.7m / EBITDA 112.0m)
Debt / FCF = 235.8 (Net Debt 339.7m / FCF TTM 1.44m)
Total Stockholder Equity = 327.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.43% (Net Income 42.7m / Total Assets 852.2m)
RoE = 13.02% (Net Income TTM 42.7m / Total Stockholder Equity 327.7m)
RoCE = 12.77% (EBIT 58.1m / Capital Employed (Equity 327.7m + L.T.Debt 127.8m))
RoIC = 7.03% (NOPAT 43.9m / Invested Capital 624.5m)
WACC = 6.50% (E(2.08b)/V(2.58b) * Re(7.91%) + D(501.7m)/V(2.58b) * Rd(0.87%) * (1-Tc(0.24)))
Discount Rate = 7.91% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 56.72 | Cagr: 19.34%
[DCF] Terminal Value 73.10% ; FCFF base≈29.2m ; Y1≈25.6m ; Y5≈20.7m
[DCF] Fair Price = N/A (negative equity: EV 332.3m - Net Debt 339.7m = -7.39m; debt exceeds intrinsic value)
EPS Correlation: 84.76 | EPS CAGR: 103.6% | SUE: -2.31 | # QB: -1
Revenue Correlation: 97.40 | Revenue CAGR: 16.60% | SUE: 0.10 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.02 | Chg30d=N/A | Revisions=-17% | Analysts=6
EPS current Year (2026-09-30): EPS=0.77 | Chg30d=+0.00% | Revisions=+50% | GrowthEPS=-31.6% | GrowthRev=+8.9%
EPS next Year (2027-09-30): EPS=0.85 | Chg30d=+0.00% | Revisions=+0% | GrowthEPS=+10.1% | GrowthRev=+8.9%
[Analyst] Revisions Ratio: +18% (up=5, down=3)